How much does a box of 2025 Venetoclax/Venetoclax cost? The latest prices and medical insurance reimbursement status

Venetoclax is a targeted drug mainly used to treat chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). This drug helps cancer cells undergo apoptosis by inhibiting the function ofBcl-2 protein, thereby effectively controlling the progression of the disease. Especially for patients who have failed to achieve good results with other treatment options, venetoclax provides a new treatment option.

In the Chinese market, the original drug of venetoclax has been launched. Common specifications include10mg×14 tablets, 50mg×7 tablets, 100mg×14 tablets and 100mg×4 tablets×7 plates. Depending on the specifications, the price of each box ranges from one thousand to four thousand yuan. It is worth noting that Venacla has been included in Class B medical insurance, but the current reimbursement policy is limited to use by adult patients with acute myeloid leukemia, which means that only patients under certain conditions can enjoy reimbursement from medical insurance.

Overseas, the price of Venekra is relatively high. For example, the Turkish version of the original drug100 mg × 112 tablets costs more than 10,000 yuan per box. Affected by exchange rate fluctuations, the specific price may change. In addition to the original drug, there are also generic drugs of Venaclava on the overseas market, such as 100 mg × 120 tablets produced by a Lao pharmaceutical factory. Its price is about more than 1,000 yuan, which is cheaper than the original drug. This provides more options for some patients with limited financial conditions.

However, although the price of generic drugs is more attractive, patients still need to be cautious when choosing, ensuring the legality of the purchase channel and the quality of the drugs to avoid adversely affecting the treatment effect. During the actual treatment process, patients should fully communicate with their doctors and choose the most appropriate treatment plan based on their condition and financial situation.

Reference materials:https://www.venclexta.com/